WHO ICTRP trial
Imaging tumor angiogenesis using 18F-Fluciclatide PET/CT in patients with…
NL-OMON21459 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON21459 |
|---|---|
| Public title | Imaging tumor angiogenesis using 18F-Fluciclatide PET/CT in patients with colorectal and pancreatic cancer |
| Scientific title | Imaging tumor angiogenesis using 18F-Fluciclatide PET/CT in patients with colorectal and pancreatic cancer |
| Primary sponsor | LUMC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Pancreatic cancer, colorectal cancer. |
| Interventions | 18F-Fluciclatide PET scan |
| Registration date | Mar 17, 2019 |
| Target size | 30 |
| Secondary IDs | NL7605;METC LUMC : P18.210 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: